Delivery Order SPE2DB22D2007-SPE2DB25FJ2YZ
- Not listed
- The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.82 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.03 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count packaging) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $7,968.71 to Amerisourcebergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker used to treat cardiovascular conditions including hypertension and heart...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $3,322.66. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the primary pharmaceutical distributor. The order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,453.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $1,932.48. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Carvedilol is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,334.92 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,111.50 for Carvedilol ER 40 mg capsules (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2YZDelivery Order
The Defense Logistics Agency awarded a $4,586.00 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used for heart failure and hypertension treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive $999.999 billion prime vendor agreement extending through December 2026. This global pharmaceutical support vehicle enables AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's significant federal procurement footprint demonstrates its established capability to fulfill competitive pharmaceutical supply requirements across multiple therapeutic domains for federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/14/25 |